NIGP 26916: Blood Derivatives

NIGP 26916 Blood Derivatives, an Item code, covers blood products and therapeutics derived from human blood—including clotting factors, immunoglobulins, albumin, and other plasma-derived medicines—that state and local health systems, hospitals, and emergency medical services procure for patient care. State and local governments buy these products primarily through established supply contracts, often leveraging group purchasing organizations (GPOs) and state cooperative purchasing vehicles to manage cost and ensure consistent access to life-critical inventory. Issuing bodies under this code typically include state health departments, county health systems, municipal hospital authorities, and emergency medical services agencies; procurement offices generally solicit these items through RFQ or standing supply agreements rather than one-time competitive bids, given the ongoing nature of demand and regulatory requirements governing blood product handling and chain of custody.

The source provided contains no recent state and local contract opportunities posted under NIGP 26916. Without posted solicitations, geographic concentration and representative recent RFPs or RFQs cannot be characterized from available procurement activity.